India
malaria vaccine market is anticipated to observe impressive growth during the
forecast period, 2024-2028. Rising awareness among people for early detection
and treatments coupled with the rising number of people suffering from malaria are
expected to augment the growth of the India malaria vaccine market. Malaria is caused by a parasite called Plasmodium, which is transmitted
to humans through the bites of infected mosquitoes. Malaria is preventable and
treatable, but the development of effective vaccines is essential to control
and ultimately eliminate this disease. Growing
incidences of malaria in the country is a major factor, which is surging the
demand for effective malaria vaccines. These malaria vaccines are vaccines that
are designed to prevent or reduce the severity of malaria, a disease caused by
parasites that are transmitted to humans through the bites of infected
mosquitoes. Furthermore, there are various other factors which are supporting
the growth of India malaria vaccine market such as growing government
initiatives, affordable vaccines, rising advancements in biotechnology, and
others.
Rise
in Occurrences of Malaria
The
high burden of malaria in India is one of the main drivers of the demand for
malaria vaccines. Malaria remains a significant public health issue in the
country, with millions of cases reported each year, particularly in rural and
underprivileged areas. Despite significant efforts to control the disease
through vector control, diagnosis, treatment, and health education, malaria
remains a major cause of morbidity and mortality in India. Therefore, there is
a surge in demand for the malaria vaccines in the country. The development of
an effective malaria vaccine has the potential to significantly reduce the
burden of malaria in India and other malaria-endemic countries. Thus, malaria
vaccine would provide a highly effective tool for preventing malaria infection,
particularly in high-risk populations, such as children under five and pregnant
women. It would also reduce the number of cases of severe malaria and the
associated morbidity and mortality. According to the World Health
Organization (WHO), India accounted for 3% of the global malaria burden in 2019,
with an estimated 247 million cases of malaria. Moreover, the burden of
malaria in India is particularly high in the states of Odisha, Chhattisgarh,
Jharkhand, and the northeast region of the country. These areas are
characterized by high rates of poverty, poor sanitation, and a lack of access
to healthcare, which contribute to the persistence of malaria. Therefore, the
rising prevalence of malaria is expected to bolster the growth of the India
malaria vaccine market in the upcoming years.
Download Free Sample Report
Increasing
Government Support
Increasing
government support is one of the crucial factors for the growth of India's
malaria vaccine market. The Indian government has recognized the importance of
malaria prevention and control and has implemented several initiatives to
address the high burden of malaria in the country. The government has also launched
several awareness campaigns to promote the use of these malaria prevention and
control measures. In addition to these initiatives, the Indian government has
provided support for the development of malaria vaccines through various
research and development programs. For instance, in 2022,
the Ministry of Health and Family Welfare of India launched a campaign named Jan
Abhiyaans with log bhaagidari (people’s participation) to enthuse and engage people
and communities to ensure that their neighborhoods, premises, and homes for
vector control and elimination. Furthermore,
the Indian government has also introduced policies to support the manufacturing
of vaccines within the country. The government's support for malaria vaccine
research, development, and manufacturing has helped to create a favorable
environment for the growth of India's malaria vaccine market. The government's
initiatives have helped to attract investment in malaria vaccine research and
development, and the policies supporting the manufacturing of vaccines within
the country have helped to create a competitive and vibrant vaccine
manufacturing industry in India.
Growing
Awareness About the Importance of Malaria Treatment
Growing
awareness among people about the importance of malaria treatment is a
significant factor that can contribute to the growth of the India malaria
vaccine market. In recent years, there has been growing awareness among people
about the importance of malaria prevention, diagnosis, and treatment. This
growing awareness has been supported by government initiatives and public
health campaigns aimed at educating people about the disease and its prevention
and treatment. As more people become aware of the importance of malaria
prevention and treatment, there is a greater demand for effective tools for
malaria control, including vaccines. Also, the growing awareness among people
about the importance of malaria treatment and prevention is also creating a
favorable environment for investment in malaria vaccine research and
development. Investors and stakeholders are increasingly recognizing the
potential of the malaria vaccine market, and the growing demand for malaria
vaccines is likely to drive investment in this area. Furthermore, the growing
awareness about the importance of malaria treatment is also creating a demand
for affordable and effective malaria vaccines. This demand is particularly
significant in India, where access to healthcare is often limited in rural and
underprivileged areas. Affordable and effective malaria vaccines can help to
reduce the burden of malaria in these areas and improve access to healthcare
for vulnerable populations.
Growing
Research & Development Activities
Research
and development (R&D) are a crucial factor that can significantly contribute
to the growth of the India vaccine market. R&D plays a vital role in the
development of vaccines, including malaria vaccines. In recent years, there has
been a significant increase in R&D investment in India. The Indian
government has implemented several initiatives to promote R&D in various
sectors, including healthcare. For example, the Department of Science and
Technology has established several programs to support R&D in biotechnology
and healthcare. The increasing focus on R&D in India has created a
favorable environment for the development of vaccines, including malaria
vaccines. Several research institutions in India are working on the development
of malaria vaccines, and the investment in R&D is likely to drive the
growth of the India malaria vaccine market. Moreover, the availability of a
skilled workforce and the presence of world-class research institutions in
India have also contributed to the growth of the R&D sector. This has
facilitated the development of innovative technologies and solutions, including
vaccines. Moreover, researchers are working on various approaches to
develop malaria vaccines, including subunit vaccines, whole parasite vaccines,
and genetically attenuated parasite vaccines. Through this research, scientists
can gain a better understanding of the parasite's biology and the immune
responses required for protection, which can ultimately lead to the
development of effective malaria vaccines. Therefore, the increasing research
& development activities in the country is expected to support the growth
of the India malaria vaccine market in the forthcoming years.
Recent
Developments
In 2023, the
India Health Fund (IHF), which is a funding initiative by Tata Trusts, has
announced its support for the two platform tools developed by Ameliorate
Biotech Pvt Ltd and Medprime Technologies, the tools are a fever panel to
detect chikungunya, dengue, malaria and microscope-agnostic AI-enabled
diagnosis software that is applicable across diseases.
In
2021, Serum Institute of India announced that it had partnered with the
University of Oxford to develop a new mRNA-based malaria vaccine. The vaccine
will use the same technology that was used to develop the Pfizer-BioNTech and
Moderna COVID-19 vaccines. The mRNA vaccine has the potential to provide a more
effective immune response compared to traditional vaccines.
For
instance, in 2019, Abbott announced its collaboration between the government of
the eastern Indian state of Odisha and Malaria No More to strengthen Odisha's
malaria detection and surveillance system, and also to eliminate malaria in the
state.
Such
initiatives, product launches, mergers and acquisitions are expected to support
the growth of the India malaria vaccine market in the forthcoming years.
Market Segmentation
India Malaria Vaccine Market
is segmented into vaccine type, roue of administration
and company. Based on vaccine type, India malaria vaccine market can be
divided into pre-erythrocytic, erythrocytic, multi-antigen, and others. Based
on route of administration, the India malaria vaccine market is divided into
intramuscular, subcutaneous, intradermal, and others. Regionally, the India malaria
vaccine market can be categorized into North India, South India, East India,
and West India.
Market Players
Gennova Biopharmaceuticals
Ltd, Zydus Group, Serum Institute of India Private Limited, Bharat Biotech
International Limited, Indian Immunologicals Limited, Panacea Biotec, Mynvax, Cadila Pharmaceuticals, Biological E
Limited, and Sanofi Pasteur are
some of the leading companies operating in the India malaria vaccine market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, CAGR for 2018-2022
and 2023-2028
|
|
Report coverage
|
Revenue forecast, Company share, Competitive landscape, Growth
factors, and Trends
|
|
Segments covered
|
Vaccine Type
Route of Administration
Company
|
|
Country scope
|
North India, South India, East India, and West India.
|
|
Key companies profiled
|
Gennova Biopharmaceuticals Ltd, Zydus
Group, Serum Institute of India Private Limited, Bharat Biotech International
Limited, Indian Immunologicals Limited, Panacea Biotec, Mynvax, Cadila
Pharmaceuticals, Biological E Limited, and Sanofi Pasteur
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet
your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, India Malaria
Vaccine Market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
·
India Malaria Vaccine Market, By Vaccine Type:
o
Pre-Erythrocytic
o
Erythrocytic
o
Multi-antigen
o
Others
·
India
Malaria Vaccine Market, By Route of Administration:
o
Intramuscular
o
Subcutaneous
o
Intradermal
o
Others
·
India Malaria Vaccine Market, By Region:
o
North
India
o
South
India
o
East
India
o
West
India
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present India Malaria Vaccine Market
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
India Malaria Vaccine Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]